Advertisement
Advertisement
CYCN
Cyclerion Therapeutics, Inc. Common Stock
3.03
USDSponsored
-0.19
-5.90%
Apr 15, 16:00 UTC -4
Closed
After-Market
3.00
-0.03
-0.99%
CYCN Earnings Reports
Positive Surprise Ratio
CYCN beat 7 of 14 last estimates.
50%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
--
/--
Cyclerion Therapeutics, Inc. Common Stock earnings per share and revenue
On Mar 31, 2026, CYCN reported earnings of -0.21 USD per share (EPS) for Q4 25, beating the estimate of -0.38 USD, resulting in a 45.82% surprise. Revenue reached 1.02 million, compared to an expected 102.00 thousand, with a 904.90% difference. The market reacted with a +7.27% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
Innate Pharma S.A. ADS
Report Date
Apr 01, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.55
Surprise
-353.80%
FAQ
What were Cyclerion Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Cyclerion Therapeutics, Inc. Common Stock reported EPS of -$0.21, beating estimates by 45.82%, and revenue of $1.02M, 904.9% above expectations.
How did the market react to Cyclerion Therapeutics, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 7.27%, changed from $1.45 before the earnings release to $1.55 the day after.
When is Cyclerion Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Cyclerion Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Cyclerion Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement